532114 Disturbance Studies of Continuous Cooling Crystallization of Carbamazepine

Xiaochuan Yang1, David A. Acevedo2, Adil Mohammad2, Naresh Pavurala3, Wei-Lee Wu4, Eleazar Wong5, Thomas O'Connor3 and Celia N. Cruz3, (1)Office of Pharmaceutical Quality, U.S. Food and Drug Administration, Silver Spring, MD, (2)U.S. Food and Drug Administration, Silver Spring, MD, (3)Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, MD, (4)Food and Drug Administration, Silver Spring, MD, (5)FDA, Silver Spring, MD
See more of this Session: Continuous Crystallization Processes
See more of this Group/Topical: Separations Division